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ABSTRACT 
 
The purpose of this clinical study was to gain better understanding about the etiology, pathogenesis, 
characteristics and outcome of pseudophakic retinal detachment (RD) after Nd:YAG laser posterior 
capsulotomy (LCT). The main principle was to compare RD of eyes with an intact posterior capsule with RD 
in eyes that had undergone LCT at the time of RD after uncomplicated cataract surgery. The hypothesis was 
that a significant number of asymptomatic retinal breaks might exist in eyes scheduled for LCT, possibly 
later causing RD. 
 
First, to identify possible differences in the type of RD and retinal breaks, a retrospective cohort study of 129 
eyes (61 with LCT and 68 with an intact posterior capsule) with pseudophakic RD was carried out (I). The 
mean number of peripheral retinal breaks was higher in the LCT group (1.7 vs. 1.1, P=0.05, Mann-Whitney U 
test). The breaks were located preferentially in the upper quadrants in the LCT group (82 of 103 vs. 48 of 77; 
P=0.024, Fisher’s exact test with Bonferroni correction) and they tended to be more frequently atrophic holes 
than horseshoe breaks (34 of 103 vs. 15 of 77; P=0.062, Fisher’s exact test) in eyes with LCT. 
 
Secondly, to find out the frequency of asymptomatic retinal breaks before LCT and to determine whether this 
procedure causes new breaks, a two-stage prospective study (II,III) was designed. At Stage I, 211 of 350 
eligible patients scheduled for LCT (220 eyes) completed three outpatient visits: before LCT, immediately 
after it and after 1 month of follow-up. An untreated, asymptomatic retinal break was found (and 
photocoagulated) in 4 of the 235 eyes (1.7%, 95%CI 0-4) before LCT. Furthermore, in 2 additional eyes (0.9%, 
95% CI 0-3) an undiagnosed RD was found. One month after LCT a new asymptomatic horseshoe tear was 
found (and photocoagulated) in 1 of 220 eyes (0.4%, 95% CI 0-3). In spite of PCO, the visualization of the 
peripheral retina was possible in 75% of eyes before LCT, and this proportion increased to 89% after LCT. 
 
At Stage II of the prospective study, patient charts of the primary inception cohort (350 eyes) were reviewed 
for retinal events. Furthermore, the 211 patients enrolled at Stage I were reinvited to one outpatient visit; 106 
patients participated. In 8 of 350 eyes (2.3%, 95%CI 1-4) a RD had occurred during the five-year follow up: 2 
in eyes studied at Stage I and 6 in eyes with unknown retinal status at the time of LCT. By univariate Cox 
regression, axial length, whether modelled as a continuous variable (HR 1.51 for each mm of increase) or 
categorized by using 25 mm as a cut-off (HR 11.1) showed a statistically significant association between RD 
after LCT (P=0.0002 and 0.0016, respectively). 
 
Finally, to assess differences in outcome of pseudophakic RD between eyes with or without LCT, a cross-
sectional analysis was done (IV). Of 138 patients invited to participate, 101 (73%) attended an outpatient visit 
(46 eyes with LCT and 55 with an intact capsule). A structured interview to determine patient-rated 
satisfaction was undertaken. The retina remained attached long-term in 92 eyes (91%, 95% CI 84-96). The 
median BCVA (in Snellen equivalents) was 0.08 before RD surgery and 0.4 at re-examination (-logMAR, 1.1 
and 0.4, respectively). No statistically significant difference was observed between LCT and control groups 
(P=0.86 Mann-Whitney U test). 80% of patients were satisfied or very satisfied with their binocular vision, 
and 62% reported no or just a little trouble with binocular vision. The median modified Cataract Symptom 
Score was 3.0 (the less points, the less symptoms, maximum 18) and the median VF-14 score was 87.5 (the 
more points, the better, maximum 100) for both groups (P=0.76 and 0.81 respectively, Mann-Whitney U test). 
 
The present series of studies, although based on relatively small numbers of patients, supports the concept 
that in some eyes, pre-existing retinal breaks may underlie pseudophakic RD after LCT. Especially when 
dealing with patients with pre-existing vitreoretinal pathology and risk factors for RD, such as high axial 
length, history of fellow RD and vitreous loss during cataract surgery, a careful retinal examination and 
follow-up before and after LCT may be recommended. 
Abbreviations 
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ABBREVIATIONS 
 
AC anterior chamber 
AL axial length of the eye 
AMD age-related macular degeneration 
AV anterior vitrectomy 
BCVA best corrected visual acuity 
BMDP a statistical software package 
CI confidence interval 
CCC continuous curvilinear capsulorhexis 
CME cystoid macular edema 
D dioptre 
ECCE extracapsular cataract extraction 
ICCE intracapsular cataract extraction 
IOL intraocular lens 
IOP  intraocular pressure 
logMAR logarithm of the minimum angle of resolution 
LCT  laser posterior capsulotomy 
Nd:YAG neodymium:yttrium-aluminum-garnet laser 
PC posterior chamber 
PCO posterior capsule opacification 
PHACO phacoemulsification 
PMMA poly(methyl methacrylate) 
PPV pars plana vitrectomy 
PVD posterior vitreous detachment 
PVR proliferative vitreoretinopathy 
RD retinal detachment 
SD standard deviation 
SE standard error 
SPSS a statistical software package 
VA visual acuity 
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2 INTRODUCTION 
 
Cataract is defined as any opacity in the crystalline lens of the eye that impairs vision. It is by 
far the most common curable cause of low vision and blindness worldwide. Because of 
cataract, 25 million individuals were blind and 110 million visually impaired at the beginning 
of year 2000.1 Cataract extraction is the most frequently performed surgical procedure in 
patients over 65 years of age. In the United States, about 1.6 million cataract operations are 
done every year.2 In Finland over 31 000 cataract extractions are performed annually, and 98% 
of them are done by phacoemulsification, the most modern method of cataract surgery.3 
 
The development of cataract surgery has led the world from the uncertain time of ‘couching 
the lens’ to the modern era of refractive surgery with a high success rate and regain of useful 
functional vision, although the speed of progress has varied in different parts of the world. 
The visual results of cataract surgery are at present very good, and serious complications, 
such as endophthalmitis and suprachoroidal hemorrhage are fortunately very rare, affecting 
less than 1 in 1000 patients in many series.4-7 The risk of retinal detachment (RD), which is 
nowadays the most common potentially blinding postoperative complication, is about 1.0% 
even after modern cataract surgery.8 In developing countries the situation is totally different. 
The modern extracapsular surgery may even become a problem compared with intracapsular 
surgery, because of lack of intraocular lenses and the means to treat posterior capsule 
opacification. 
 
Posterior capsule opacification (PCO) is a very frequent problem after cataract surgery, which 
currently necessitates a posterior capsulotomy (LCT) with neodymium:yttrium-aluminum-
garnet (Nd:YAG) laser in one fourth to fifth of eyes that have undergone cataract extraction 
and intraocular lens (IOL) implantation.9 Even though laser capsulotomy is easy to perform, it 
carries risks. In addition to intraocular lens pitting, cystic macular edema and intraocular 
pressure rise, it is thought to increase the risk of RD four times compared with uncomplicated 
extracapsular cataract extraction only. 4;10-12 
 
The exact mechanisms leading to RD after LCT are not known, even though several theories 
are proposed. It is commonly believed that Nd:YAG laser treatment initiates structural 
changes in the anterior vitreous, resulting in vitreous liquefaction, posterior vitreous 
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detachment and, if any abnormal vitreoretinal attachments exist, in retinal breaks and 
detachment.13-19 
 
The basic type and general outcome of pseudophakic RD have been reported but many details 
remain unanswered and unexplored. The present series of studies was designed to get more 
information especially of eyes that have undergone capsulotomy before RD, and to be able to 
manage this group of patients in an increasingly rational way. 
 
Figure 1. The cross section of the eye 
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3 REVIEW OF LITERATURE 
3.1 CATARACT SURGERY 
3.1.1 Epidemiology of cataract  
Any opacity in the lens that impairs vision is called a cataract. It is estimated, that almost two 
thirds of 65-74 year-old people lens opacities of some degree are present, and about one-fourth 
of individuals in this age group have decreased vision because of lens opacities.20;21 The main 
risk factor for lens opacification is aging, although other etiologies for cataract, i.e. trauma, 
radiation, use of corticosteroids, systemic disorders like diabetes mellitus and atopic 
dermatitis, and ocular conditions such as uveitis, retinis pigmentosa, degenerative myopia 
and glaucoma surgery are also known.20;21 Although usually thought to affect equally men 
and women, it have also been reported, that cataract extractions are performed more 
frequently in female patients.5 This difference have been explained only by the fact that 
females live longer. The suggested reasons for the difference have been a higher prevalence of 
cataract in females, and social reasons, such as tendency to experience more functional 
impairment and request surgery with higher visual acuities than males. Although primarily a 
disease of the elderly, cataract can occur at any age. About one third of all congenital cataracts 
are hereditary.20 Infantile cataracts are of particular importance as a cause of amblyopia, 
strabismus and nystagmus, and they sometimes have to be operated on even in very young 
children. Age-related cataract is a multifactorial disease in which genetic, environmental, 
socioeconomic and biochemical factors may have an additive effect.20;22 Because of this 
diversity, no method of preventing the development of cataract has yet been successful. 
 
3.1.2 General development of cataract surgery 
 
Although primitive types of cataract surgery have been performed for thousands of years, the 
history of sophisticated cataract surgery is relatively short. Up to the 18th century the purpose 
of the operation was to couch or to displace the opaque lens from the visual pathway. This 
was done with a sharp needle with the patient sitting in a chair. After a temporal paracentesis 
the lens was dropped down ‘into the depths of the eye’.20;23 In 1745 Daviel was probably the 
first surgeon to operate through the cornea to extract the cataract.4 However, with the 
extracapsular technique, in which the lens is removed from the lens capsule, it was necessary 
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to wait until the cataract was nearly mature, because nonopaque parts of the lens were 
difficult to remove. Therefore, when the intracapsular method (ICCE), enabling total removal 
of the lens, was introduced some years later, it quickly and almost completely replaced the 
extracapsular techniques for a considerable period of time. 
 
Even when performed successfully, cataract extraction resulted in disturbing visual handicap, 
aphakia. The traditional method of correcting aphakia by spectacles created visual problems 
such as magnification and reduced peripheral vision. The next solution, contact lenses, 
magnified objects significantly less without severe peripheral distortions. However, they were 
useful only to patients, who could handle them adequately and wear them comfortably, which 
was often difficult, if not impossible, for elderly people with several systemic diseases. 
 
The idea of intraocular lenses emerged from the difficulties in providing good visual 
rehabilitation for aphakic patients. Sir Harold Ridley implanted the first IOL on February 8, 
1950, after a planned extracapsular cataract extraction (ECCE) in a 45-year old female. The 
very first idea of an intraocular lens, however, came from a medical student.2;4 
 
Due to optical advantages, the intraocular lens quickly became the standard method for 
correcting aphakia once appropriate lenses and instruments were made widely available in 
the late 1980’s.2;20;23;24 The method of disintegrating the lens with phacoemulsification, 
introduced by Charles Kelman, and the development of viscoelastics and IOLs have made it 
possible to remove the lens and to implant a foldable IOL through very small incisions. Also 
modern instruments minimizing surgical injury, advantages of in-the-bag fixation, continuous 
curvilinear capsulorhexis (CCC) and hydrodissection techniques have resulted in safer and 
more rapid rehabilitation, but also differences in complications.4;20;24  
 
3.1.3 Complications  
The intra- and postoperative complications of cataract surgery are nowadays less severe than 
at the time of ICCE. However, concurrently with extracapsular technique, a new problem with 
posterior capsule opacification arose. Comparing posterior segment complications after 
planned extracapsular cataract extraction and phacoemulsification, no significant differences 
have been found between these two techniques.25;26 The most serious perioperative 
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complications of cataract extraction, which have influence on the posterior segment of the eye, 
are listed here. 
 
Posterior capsule rupture, which precedes vitreous loss, is the most common of these 
complications, and is reported to occur in 0.2%-16% of operated eyes.26-34 It is more likely to 
happen in eyes with small pupils, hard nuclei, or exfoliation syndrome. If posterior capsule 
ruptures and vitreous loss occurs, the risk for RD and other posterior segment complications 
is increased.8;35;36  
 
The expulsive suprachoroidal hemorrhage, which is due to rupture of a ciliary artery, is 
fortunately a rare complication occurring in 0.03-0.06% of patients after phacoemulsification 
and IOL implantation.4;37;38 
 
Purulent endophthalmitis can occur within the first postoperative days or later as a chronic 
intraocular infection. The incidence of infectious endophthalmitis after cataract surgery has 
been estimated to be 0.07%-0.13%.4-7;37 It is usually managed with intraocular, topical and 
systemic antibiotics combined with corticosteroid therapy and, if BCVA is light perception, 
vitrectomy.39 The visual prognosis in endophthalmitis is dependent on time of onset of the 
endophthalmitis and the virulence of the pathogen.7 
 
Following cataract surgery, cystoid macular edema (CME) is the most common cause of 
unexpected visual loss. It has been estimated, that fluorescein angiographic CME can occur in 
up to 50% of patients 4-8 weeks postoperatively but clinical CME occurs in less than 3% of 
patients.4;40 It is assumed to be caused by postoperative inflammatory reaction or vitreous 
traction. Intraoperative complications, such as posterior capsule rupture and vitreous loss 
predispose to CME.35;41 
 
Retinal detachment, which is the most common potentially blinding complication of cataract 
extraction, occurs nowadays in 0.05-1.7% of persons after phacoemulsification and posterior 
chamber IOL implantation (See 3.5). 
 
Other intraoperative complications of cataract surgery include wound complications, 
detachment of Descemet’s membrane, thermal injury from the phaco tip, tears in 
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capsulorhexis, iris prolapse, problems with IOL insertion, anterior segment hemorrhage and 
dropped nucleus. Postoperatively the most common are astigmatism, corneal edema, 
hyphema, intraocular pressure elevation, sterile inflammatory reactions and IOL 
decentration.4;20 Because not directly related to the scope of this study, they are only briefly 
mentioned here. 
 
3.1.4 Evaluation of outcome  
 
As a result of the transition from intracapsular cataract surgery to small incision surgery, 
advertising of and expectations relating to cataract surgery have increased dramatically. The 
associated needs for accurate methods for evaluating the outcome of cataract surgery have 
brought new methods of analysis. 
 
The outcome of cataract surgery can be classified according to subjective and objective 
findings. Subjective findings of functional vision are evaluated best with interviews or 
questionnaires, and several of them are available.5;26;42-50 Perhaps the most widespread is the 
visual functioning index, VF-14, introduced in 1994 to measure visual impairment caused by 
cataract.42 Recently, it has also been used in other settings as well.51-53 Objective measures of 
functional vision include also other parameters besides best corrected visual acuity (BCVA) - 
such as uncorrected visual acuity, contrast sensitivity, glare disability, visual field and color 
vision. They all measure different aspects of visual performance providing a general view of 
the functional vision. Evaluation of this kind is also valuable because of the still long waiting 
lists and consequent economic pressure. 
 
3.2 POSTERIOR CAPSULE OPACIFICATION (PCO) 
3.2.1 Pathogenesis  
The posterior capsule is a basement membrane forming a complete sheath around the lens. It 
is thickest anteriorly, 14-20µm, and much thinner posteriorly, only 3-4µm, because the lens 
epithelium stops at the equator of the adult lens.20;54 
The pathogenesis of PCO has been well documented in the literature. Most cases of clinically 
significant PCO are caused by proliferation and migration of residual lens epithelial cells and 
their derivatives after cataract surgery.55-62 In the normal lens, the epithelium consists of 
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cuboidal anterior epithelial cells, which are continuous with the cells of the equatorial lens 
bow (Figure 2.).58 These two types of lens epithelial cells react in different ways following 
external stimuli.  
 
Figure 2. A schematic drawing of the lens and the epithelial cells 
 
The anterior epithelial cells primarily differentiate into spindle-shaped, fibroblast-like 
myofibroblastic cells, which are able to contract.58;63 The contraction may cause folds and 
wrinkles of the posterior capsule similar to those seen in anterior polar cataracts.55 In more 
advanced stages, white fibrotic opacities develop, leading to increasing capsular wrinkling 
and decreasing best corrected visual acuity (BCVA).58;63  
 
The equatorial epithelial cells comprise the germinal cells, which are the primary cells in the 
origin of PCO. They normally migrate centrally from the lens equator and contribute to the 
formation of nucleus, epinucleus, and cortex throughout life. Instead of undergoing a fibrotic 
transformation, they tend to migrate backward and form large, balloon-like clusters called 
pearls. They were first noticed by Hirschberg in 1901, and then by Elschnig in 1911, and are 
nowadays referred to Elschnig’s pearls.1 The diameter of these cells is in the range of 5-120µm. 
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Anterior 
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Each pearl probably represents the aberrant attempt of one epithelial cell to differentiate into a 
new lens fiber.58;62;63  
 
As epithelial cells proliferate and migrate onto the posterior capsule, two main types of 
opacities are often clinically differentiated. It is thought that anterior epithelial cells play a 
major role in the pathogenesis of the fibrosis-type of PCO (Figure 3A), and equatorial 
epithelial cells account for the pearl-type of PCO (Figure 3B).1;58;62-64 The equatorial cells are 
also responsible for the formation of Soemmerring’s ring, which is a doughnut-shaped lesion 
composed of retained or regenerated lens cortex and cells, and which may form after any type 
of disruption of the anterior lens capsule.63;65 Clinically significant PCO decreases visual 
acuity, impairs contrast sensitivity, increases glare and can cause monocular diplopia.58;66 
 
Figure 3. A  Fibrosis – type of  B  Pearl – type of 
posterior capsule opacification   posterior capsule opacification 
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3.2.2 Incidence  
Clinical studies of PCO differ considerably in many ways. In many studies, a clear definition 
of significant PCO is lacking, the methodology is inaccurate and different surgical techniques 
and IOL styles are used.9;37;67 Also the follow-up times are very different, which makes 
comparisons difficult. However, it is clearly shown, that an inverse age-related tendency 
toward PCO formation exists. In general, the older the patient at the time of cataract surgery, 
the lower the incidence of PCO.58;68-70 It is estimated that nearly all pediatric patients will 
develop PCO within two years of surgery unless a primary capsulotomy or other preventive 
measures are implemented.22;58 The incidence of PCO also increases with time after cataract 
surgery, and studies with very short follow-up times are thus inaccurate.  
 
In a review of 90 studies related to complications following cataract extraction with IOL 
implantation, the pooled percentage of eyes experiencing PCO was 20%.37 In a meta-analysis 
of 49 studies, published in 1998, the overall pooled estimate of the incidence of PCO was 12% 
at 1 year, 21% at 3 years and 28% at 5 years after surgery.9 It was concluded that visually 
significant PCO develops during the first 5 years after surgery in more than 25% of patients 
undergoing standard extracapsular cataract extraction and phacoemulsification with posterior 
chamber IOL implantation. 
 
The incidence of PCO has also been shown to be dependent on the shape and material of the 
IOL. When comparing PMMA, silicone and acrylic IOLs, the PMMA lenses have the highest 
PCO rates (9-50%), and the acrylic lenses the lowest (0-14%).1;40;65;67;69;71-84  
 
3.2.3 Prevention  
Based on the pathogenetic factors, the principles of prevention of PCO are to minimize the 
amount of retained epithelial cells and lens cortex and, if some cells do remain, to provide a 
secondary line of defense to prevent them from migrating centrally over the visual axis.58;62-
65;67;70;85;86 No generally accepted method of preventing PCO is yet available, but the main 
principles are summarized here. 
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3.2.3.1 Intraoperative techniques 
It has been noticed that, in addition to ensuring the overall safety of the operation, careful, 
subcapsular hydrodissection of the nucleus and cortical layers in association with a 
continuous curvilinear capsulorhexis (CCC) may be more successful than previously assumed 
in decreasing the frequency of PCO.62;63;65;71;87-91 Creating a CCC slightly smaller in diameter 
than that of the IOL optic places the edge of the capsulorhexis on the anterior surface of the 
optic. This helps to provide a tight fit of the capsule around the optic and also seals the optic 
from the surrounding aqueous humor, which contains macromolecules and inflammatory 
mediators.1;65;71;92 
 
Optimal positioning of the IOL is thought to be important in reducing PCO.58;63;71;87 In the late 
1980s, in-the-bag fixation was achieved in 30% of cases.84;90 With modern methods of surgery, 
the IOL is positioned in the bag in over 90% of eyes.65;84;90 The barrier effect against lens 
epithelial cells is maximal, when the lens optic is fully in-the-bag and in direct contact with the 
posterior capsule. When one or both haptics are out of the bag, a potential space exists that 
allows a route for ingrowth of cells toward the visual axis. 
 
3.2.3.2 IOL design 
The IOL design, including choice of lens material, has been noticed to be an important factor 
influencing the development of PCO.86;91;93-96 The bioactivity of the IOL (its ability to regulate 
epithelial cellular proliferation) is postulated to explain the difference in PCO rates with 
different IOL materials.65;97;98 When the IOL allows a single layer of lens epithelial cells to 
adhere simultaneously to both posterior capsule and the IOL, producing a sandwich-like 
pattern, this will probably reduce the amount of epithelial cells inside the posterior capsule 
resulting in smaller amounts of PCO.97;98 
 
The influence of IOL lens design on PCO, especially posterior angulation of the haptic and 
posterior convexity of the optic, has been recognized for many years.64;99;100 Virtually all IOLs 
are manufactured now in a posterior convex or biconvex format so that the posterior capsule 
and optic surface are apposed. As a result, capsular surface is stretched radially and flattened, 
so there should be no room for the cells to pass this mechanical barrier and migrate onto the 
center of the posterior capsule.70;86;95;99-104 
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3.2.3.3 Pharmacological agents  
To prevent PCO, instillation of several drugs on the posterior capsule during cataract surgery 
has been tried. The main aim is to kill the remaining lens epithelial cells, to inhibit their 
proliferation and migration and to minimize intraocular inflammatory reaction after surgery. 
Antimetabolites, cytotoxic drugs, immunotoxins and antiprostaglandins have all been used 
effectively in vitro and in vivo in experimental animal studies.105-113 The problem is limiting the 
effect to the lens epithelium and protecting the rest of the eye. Animal experiments have 
documented toxic effects on corneal endothelial, iris, ciliary pigment epithelium and retinal 
cells.86;93 A practical, effective and safe method of preventing PCO with pharmacological 
agents is not yet available. 
 
3.2.4 Treatment  
Before the era of Nd:YAG laser posterior capsulotomy, there were two possibilities to treat 
PCO; primary or secondary surgical capsulotomy and surgical polishing of the posterior 
capsule.114-120 Soon it was noticed that to minimize postoperative complications such as CME 
or RD, it is important to keep the posterior capsule intact if possible.121 Aspiration of 
Elschnig’s pearls and polishing of the posterior capsule may be performed especially in highly 
myopic eyes that may benefit from preservation of an intact posterior capsule. However, it is 
often a temporary solution because recurrence of Elschnig’s pearls is very common. 
 
After the introduction of the Nd:YAG laser, LCT became the method of choice in treating PCO 
with good results as regarding visual acuity, contrast sensitivity and lack of glare.40;66;117;122-125 
Alternatives to LCT are also studied, e.g. polishing with a neodymium:yttrium-lithium-
fluoride picosecond laser. A polishing effect in an artificial latex posterior capsule was 
achieved, but with higher energy settings the IOL was damaged.126  
 
3.3 Nd:YAG LASER POSTERIOR CAPSULOTOMY (LCT) 
3.3.1 Principles of Nd:YAG laser 
The introduction of Nd:YAG laser (neodymium:yttrium-aluminum-garnet) to eye surgery 
took place in 1973, when Beckman used it for thermal cyclodestruction.127 In the same year, 
Krasnov showed that optical breakdown of transparent non-absorbing tissue by high power 
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pulsed laser was possible.128 The use of the Nd:YAG laser was permanently established in 
ophthalmology independently by Fankhauser in Switzerland129 and Aron-Rosa in France 
(Figure 4A and B).130;131  
 
The active element of a neodymium laser consists of neodymium atoms embedded in a crystal 
structure. The most successful host for neodymium lasers is the yttrium-aluminum-garnet 
crystal-Y3Al5O2, known as YAG. The Nd:YAG laser is pumped by a gas discharge lamp. The 
pump energy is absorbed by the neodymium atoms, which are then excited into a higher 
energy level. Finally a highly irradiating light pulse at a wavelength of 1064 µm is emitted. 
The laser beam is invisible but is focused to the target tissue with a helium-neon guiding laser 
beam. When focusing the emitted laser energy into a very small region, a sudden temperature 
rise of approximately 10 000°C is generated.131-135 In such a temperature all matter is 
transformed into a gaseous state. All atoms of this gas become ionized, releasing free 
electrons. The neutral atoms, emerged ions and free electrons all move at high velocity and 
collide with each other. This state of matter is referred to as plasma, because it differs in its 
physical properties from normal gas. The phenomenon itself is designated optical 
breakdown.131-133;135  
 
Two main types of Nd:YAG laser devices exist: Q-switched and mode-locked. In a Q-switched 
laser, the laser pulse is typically 8 to 15 nsec in duration. A mode-locked laser pulse train is 
composed of seven to eight individual pulses, each of which has a duration of 10 to 15 psec; 
the total pulse train lasts for 30 nsec. In both models, the intention is to create very brief pulses 
of energy.133 
 
The Nd:YAG laser causes an ionizing, photodisruptive effect. The instantaneous high 
temperature rise generates an acoustic and hydrodynamic shock wave that results in tissue 
disintegration. It is thought, that several physical phenomena are responsible for the 
photodisruptive damage observed clinically; ionization, high temperature, generation of UV 
light-induced photochemical processes, acoustic transients, electrical field stress and 
cavitation.131-135 
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Figure 4. A  A schematic drawing of LCT 
 
 
Figure 4. B  Posterior capsule after LCT 
 
3.3.2 Complications  
Even though LCT was first thought to be a very safe, non-invasive method to treat PCO, 
several complications of LCT have been reported.136 Indeed, because of the abruptness of the 
plasma formation and the acoustic and hydrodynamic shock wave that it produces, the Nd: 
YAG laser can cause severe complications, especially if used incorrectly. 
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A frequent complication is damage to the intraocular lens (IOL), which occurs even in 20-40% 
of cases.136-143 It is more likely to occur if the lens is in close proximity to the posterior capsule 
and if the membrane is thick.136 There appears to be a direct correlation between IOL damage 
and the total laser power used, the number of laser pulses, and the number of pulse trains 
used.136 The resulting pitting or marking of the IOL is thought to be mostly harmless, but 
some evidence of inducing glare and contrast vision has been published.144  
 
Another frequently reported complication is rupture of the anterior hyaloid face, which occurs 
in 10-30% of cases.13;136;141;143 Instead of a usual consequence, it is thought to be a complication, 
because it allows the vitreous to move anteriorly. In aphakic eyes this anterior movement may 
cause a pupillary block and induce CME, RD and late-onset corneal edema.  
 
Another major complication of Nd:YAG capsulotomy is increased intraocular pressure, which 
can occur in up to 30% of cases.13;136;137;139;140;142;143;145-150 The IOP rise is usually transient but 
can also be permanent. It is seen in eyes with pre-existing glaucoma as well as in 
normotensive eyes. Because antiglaucoma therapy (e.g. topical apraclonidine) is now used 
routinely, is it a rare complication, but nevertheless glaucoma patients are recommended to 
have careful follow-up for persistent pressure elevations.136;137;146;147 
 
It is believed that the incidence of CME following LCT ranges from 0.4% to 3%. When 
evaluated with fluorescein angiography, the frequency increases up to 13%.136;139;141-143;145;147-153 
It is less likely to occur if the interval between cataract surgery and Nd:YAG laser 
capsulotomy is long, at least 3 months.136;154;155 
 
Intraocular infection has been reported to occur after LCT in rare cases. It is thought to be due 
to release of pre-existing bacteria encapsulated between the IOL and posterior capsule.156;157 
Other less frequently encountered complications include corneal edema, bleeding, iris 
damage, IOL luxation into the vitreous cavity, pupillary block, iritis, vitreous opacification, 
vitritis, retinal hemorrhage and prolapse of vitreous, intraocular gas or silicone into the 
anterior chamber.136-140;142;143;147;148;158;159 
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3.3.3 Effects on vitreoretinal structures 
The effects of Nd:YAG laser on vitreoretinal structures have been studied both in 
experimental animals and in clinical practice. The transmitted light, thermal energy, shock 
waves, and re-emitted light all have to be considered as potential hazards to vitreoretinal 
structures.132-135;160;161  
 
It is thought that the laser light transmitted beyond the focus is divergent and will thus spread 
over a large area of the retina, unless coming too close to it.135;160;162;163 In an experimental 
study of vitreous membranes in rabbit eyes, Q-switched Nd:YAG was able to cut vitreous 
membranes up to 4 mm from the retinal surface with single pulse energies of up to 4 mJ 
without fluorescein angiographic evidence of retinal injury. When treating strands closer to 
the retinal surface, injury was documented in five of seven cases164. In another animal study, 
laser pulses could not be focused within 2 mm of the retina without substantial risk of retinal 
damage.162  
 
In human eyes, accidental retinal injuries of the macular area have also been reported. In those 
cases rupture of a retinal vein, hemorrhage, macular or paramacular hole and damage to small 
areas of pigment epithelium were recorded.165-167 
 
The temperature in the plasma becomes very high for a short period of time. Tissues at or near 
the zone of optical breakdown are subject to extremely high temperatures with vaporization 
and damage.133-135 This heat is localized and is thought not to cause damage more than 200 
microns from the center of the focal zone. The shock wave effect (acoustic transient) of the 
ultrasonic frequencies can be seen most easily, when breakdown occurs near a vitreous strand, 
which will vibrate strongly.135 The re-emitted light flash observed at the optical breakdown 
zone contains a broad band of visible and ultraviolet radiation. This light has little energy and 
is not known to have deleterious effects in the eye.133-135;168  
 
Animal studies have shown diffuse changes in the vitreous body when optical breakdown 
occurs in the anterior vitreous near the posterior capsule. In a study with monkey eyes a 
decrease in viscosity of vitreous gel after Nd:YAG laser treatment of either the posterior 
capsule or the mid-vitreous was detected.169 It was thought that these changes represented 
increased vitreous liquefaction and probably resulted from a depolymerization process caused 
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by acoustic transients accompanying the laser irradiation.169 However, in another study in 
rabbits no direct deleterious effects on the structural integrity of the normal vitreous body 
were noticed.170 
 
3.4 RHEGMATOGENOUS RETINAL DETACHMENT (RD) 
3.4.1 Pathogenesis  
In rhegmatogenous RD, the neuroretina separates from the pigment epithelium, because fluid 
from vitreous cavity passes under the neuroretina through a retinal break. The series of events 
usually begins from vitreous liquefaction, which induces posterior vitreous detachment 
(PVD). The latter causes a retinal break at the site of former vitreoretinal adhesion. The normal 
retinal attachment is maintained by adhesive-like mucopolysaccharides in the subretinal 
space, oncotic pressure differences between the choroid and subretinal space, hydrostatic 
forces related to intraocular pressure, and metabolic transfer of ions and fluid by the retinal 
pigment epithelium.8;40;171;172 Retinal detachment occurs when the combination of factors that 
promote retinal detachment overwhelms the normal attachment forces. 
 
3.4.1.1 Retinal breaks 
Retinal breaks are classified as holes and tears.8;40 Retinal hole is a full-thickness retinal defect 
that is not thought to be associated with persistent vitreoretinal traction. It occurs usually as a 
result of localized atrophy of the retina especially in association with retinal lattice 
degeneration in myopic or otherwise elongated eyes. Retinal tears are usually produced by 
PVD and subsequent vitreoretinal traction at the site of a significant vitreoretinal adhesion 
such as the posterior borders of vitreoretinal degenerations or scars. Vitreous traction usually 
persists at the edge of a tear, resulting in progression of RD. The incidence of retinal breaks in 
autopsied individuals over 20 years of age ranges from 4 to 11%.8;40;173 
 
3.4.1.2 Posterior vitreous detachment 
The vitreous is a gel-like structure, about 4 ml in volume, that fills the posterior cavity of the 
eye. It consists mainly of water (99%), but contains also a meshwork of fine collagen fibrils and 
spheroid hyaluronic acid molecules.8;20;40 With aging, several structural changes occur in the 
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vitreous. The central parts become liquefied and the configuration of hyaluronic acid 
molecules changes. These changes lead gradually to PVD, a separation between the posterior 
vitreous cortex and the internal limiting membrane of the retina.8;20;40 
 
The time point of PVD is individual. In an autopsy study PVD was present in less than 10% of 
patients under the age of 50, and in 63% of patients above the age of 70.174 In a clinical survey, 
however, only 11% of eyes among 65 to 69 year-old patients exhibited a complete PVD. In the 
age group of 80 to 89 years, 46% had a complete PVD.175  
In association with acute, symptomatic PVD, 4-46% of eyes have been reported to develop a 
peripheral retinal break.176-183 The average risk for these breaks of progressing to retinal 
detachment is reported to be 35%.8 Therefore, any retinal break associated with acute 
symptoms is often prophylactically photocoagulated.8;40;179;184-186 Asymptomatic retinal breaks 
in phakic eyes with no RD in the fellow eye do not usually progress to RD even after PVD, 
and prophylactic treatment is recommended only if subretinal fluid accumulates.40;184;187-193  
 
3.4.2 Predisposing factors 
In the general population, the annual incidence of RD is approximately 1:10 000.8;194 However, 
a variety of ocular conditions are associated with increased prevalence of vitreous liquefaction 
and PVD, and with increased number and extent of vitreoretinal adhesions. These conditions, 
based on the pathogenetic factors, also are associated with increased risk for RD. Particularly 
important risk factors for RD in phakic eyes are high myopia, lattice degeneration, history of 
RD in the fellow eye, and blunt or penetrating ocular trauma.8;40;195  
 
In a case-control study 253 patients with idiopathic RD were compared with 1,138 controls.196 
It was found that an eye with a refractive error of -1 to -3 D had a fourfold risk of RD, and if 
the refractive error was greater than -3 D, the risk increased 10-fold compared with a 
nonmyopic eye.196 Degenerative changes in the peripheral retina and vitreous are thought to 
predispose the myopic eye to RD.8 Retinal breaks and lattice degeneration, important risk 
factors for RD, are also reportedly more common in myopic eyes8;197 Finally, liquefaction of 
vitreous, resulting in PVD, occurs earlier than average in myopic eyes.8;40 
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Lattice degeneration of the peripheral retina is a condition in which retinal thinning is 
associated with a pocket-like liquefaction and separation of overlying vitreous. A condensed 
vitreoretinal adhesion also occurs at the margin of lattice lesions. Lattice degeneration is 
present in 11% of autopsy eyes, occurring equally in men and women, and increases in 
incidence with age and AL.8 Up to 25% of areas of lattice degeneration include a retinal break.8 
In eyes with a rhegmatogenous RD, lattice degeneration is present in up to 30%.8 However, 
the great majority of eyes with lattice degeneration are not at a particularly high risk of RD. 
The risk for developing RD in an otherwise normal eye is estimated to be small.198 Prospective 
randomized trials of prophylactic therapy to prevent RD have not been performed, but 
routine laser treatment of lattice degeneration and asymptomatic retinal holes in otherwise 
normal eyes is not recommended.8;184;198-200 
 
Of patients with RD, up to 20% are reported to have asymptomatic retinal breaks in the fellow 
eye.8;201;202 The recommendations about prophylactic therapy of lattice degeneration and 
retinal breaks in fellow eyes are controversial.8;184;187;188;201-206 It has been noticed that RD can 
frequently develop from a new retinal break in previously healthy retinal areas.179;180;203;204;207 
Risk factors of RD may also be additive. Blunt trauma in a myopic eye with degenerative 
changes of peripheral retina is more likely to be complicated with RD than in a normal eye 
without pathologic conditions. 
 
3.4.3 Prevention 
Although prevention of RD is an important goal, so far there have not been prospective, 
double-blinded clinical trials reported to test the true value of preventive treatment.199 
According to its pathophysiology, RD could be avoided by preventing vitreous liquefaction 
and associated PVD, relieving vitreoretinal traction or creating a chorioretinal adhesion 
around vitreoretinal adhesions and retinal breaks. For practical reasons, the last of these three 
ways is the only one used, created by laser photocoagulation or cryocoagulation. It is 
generally accepted, that symptomatic patients with a horseshoe-shaped tear should be treated 
prophylactically because of increased risk of RD. However, other indications of preventive 
treatment remain controversial. It is often recommended that in patients with 
rhegmatogenous RD, degenerative retinal lesions of fellow eyes, such as lattice degeneration, 
round holes or flap tears should be treated even in asymptomatic patients. Laser 
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photocoagulation is preferred over cryopexy because chorioretinal adhesion appears more 
quickly, it causes less breakdown of the blood-retina barrier, and it may have a lower 
incidence of epiretinal membrane formation. No generally accepted guidelines exist of 
prophylactic treatment of retinal breaks in eyes planned to undergo cataract surgery or 
LCT.8;40;184;199;200;206;208-210 
 
3.4.4 Treatment  
The main goal in managing RD is closing every retinal break to re-establish the physiologic 
conditions that normally maintain the contact between the neural retina and pigment 
epithelium. Long-term closure of retinal breaks may also require permanent reduction or 
elimination of vitreoretinal traction. The minimal procedure to safely achieve the goal is 
recommended.211;212 The main options for the management of primary rhegmatogenous RD 
are laser demarcation, cryocoagulation, pneumatic retinopexy, scleral buckling (segmental or 
encircling), and vitrectomy. The scleral buckling and creation of a chorioretinal adhesion 
around each break is nowadays the most frequent technique. Vitrectomy and combinations of 
both techniques are performed if failure of scleral buckling is likely, such as in eyes with a 
very large tear, no visible breaks, posteriorly located tears and dense vitreous hemorrhage. 
 
3.4.5 Outcome  
Nearly all symptomatic rhegmatogenous retinal detachments progress to total blindness 
unless they are repaired. Until 70 years ago, rhegmatogenous RD was an essentially incurable 
disorder. Nowadays recent technical advances and better understanding of the pathogenesis 
of RD have lead to excellent results especially anatomically.213-216 The best results are achieved, 
when primary RD is operated on before the development of macular detachment.215;217-221 The 
outcome of RD surgery can be expressed in several ways; anatomical, visual and functional.  
 
3.4.5.1 Anatomical outcome 
The result is anatomically good, when the retina returns to its normal position with no 
residual subretinal fluid, and remains attached. With recent surgical techniques the final 
anatomical success rate (with one or more operations) is 90-98%.211;215;216;222-228 The two most 
common reasons for failure are proliferative vitreoretinopathy (PVR) and a failure to close all 
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retinal breaks.8;211;215;220;222;223 In PVR, primarily retinal pigment epithelial and glial cells grow 
on both the inner and outer retinal surfaces and on the vitreous face, forming membranes. 
Contraction of these membranes causes fixed retinal folds, traction and generalized retinal 
shrinkage. As a result, the primary retinal breaks may reopen, new breaks may occur, or a 
tractional detachment may develop.40;229  
 
3.4.5.2 Visual outcome 
The visual outcome after RD surgery is generally considered good, if BCVA is 0.5 or better in 
Snellen fractions. Visual and anatomical outcome are often somewhat different; the retina may 
remain attached, but the retinal function may not be well preserved. The visual results depend 
on the extent of damage to the macula caused by the RD. If the macula becomes detached by 
subretinal fluid, some degree of permanent damage to vision usually occurs in spite of 
surgical reattachment, however early. The most important predictors of visual recovery after 
RD surgery are preoperative BCVA and the duration of macular 
detachment.215;216;218;219;221;223;228;230-236 However, visual function may reimprove in the long term 
especially in younger patients and after macular detachment of short duration.218 
If the macula is detached, only 50% of patients gain a BCVA of 0.5 or better.8;216;217;221 In eyes 
with attached macula, up to 80-90 % can gain a better BCVA than 0.5. It must also be 
remembered though that about 10% of eyes with almost normal vision preoperatively 
undergo some degree of visual loss after a successful repair of a macula-sparing detachment. 
Among others the reason for this is gradually developing PVR in the form of epiretinal 
membranes.8 
 
3.4.5.3 Functional outcome 
The functional outcome has been measured more often after cataract than after vitreoretinal 
surgery with several questionnaires, such as VF-14, Cataract Symptom Score and 
others.10;26;32;42-46;48-50;237-239 Only a few reports of vitreoretinal surgery have been published so 
far, and none of them was related solely to RD surgery.53;240-242 The first study, published in 
1993, comprised patients with RD, diabetic retinopathy, retinal vein occlusion, and other 
vitreoretinal diseases. It was based on a five-item questionnaire answered by 123 patients.242 
In 1997 and 1998, binocular visual function was evaluated in 187 patients after vitrectomy for 
uncomplicated and complicated RD and macular pucker. The conclusion was that visual 
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function improved after surgery even among those who had normal vision in the fellow 
eye.240;241 The VF-14 was recently tested with 546 patients with vitreoretinal disease, 14% of 
whom had RD. The median VF-14 score was 92, but the score after RD surgery was not 
separately reported.53 
 
3.5 PSEUDOPHAKIC RETINAL DETACHMENT 
3.5.1 Special risk factors  
The baseline risk factors for pseudophakic RD are the same as mentioned before, i.e. myopia, 
lattice degeneration, and history of RD in the fellow eye.10;210;243-252 However, the cataract 
surgery itself by changing intraocular circumstances, is also a risk factor for RD. A physiologic 
barrier composed of anterior hyaloid, posterior capsule, zonules, and posterior chamber IOL, 
exists between the anterior and posterior parts of the eye after uncomplicated extracapsular 
cataract surgery. After extracapsular cataract surgery, the risk of pseudophakic RD is reported 
to be 0.05-1.7%.6;249;253-260 The risk associated with modern phacoemulsification is thought to be 
even smaller, but no prospective randomized studies comparing these procedures have been 
published.  
 
The barrier effect of the lens diaphragm is lost at least to some extent after posterior capsule 
rupture or capsulotomy, and even more after ICCE, and the eye is then subject to changes in 
the vitreous and vitreoretinal interface and thus to an increased risk for RD.121;155;246;253;257;261-271 
After ICCE, the risk of RD is reported to be 0.8 - 5.7%.249;256;272-280 If the posterior capsule 
ruptures, vitreous loss occurs, or secondary capsulotomy is performed, the risk of RD is 
reported to be fourfold as compared with uncomplicated cataract extraction only.10-12;253 
 
In a study of 201 postmortem eyes, posterior vitreous detachment was present in 84% of eyes 
following ICCE as compared with 40% after ECCE with an intact posterior capsule. If a 
surgical capsulotomy had been done, the frequency of PVD was found to be nearly equal to 
ICCE (76%).281 It is thought that the high incidence of retinal tears in aphakic eyes is probably 
due to the greater freedom of movement of the vitreous, when the lens no longer supports it. 
This increased movement results in greater pull on the peripheral retina, if the vitreous is still 
attached to it.268;269;271;282;283  
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In one post-mortem study the amount of hyaluronic acid in vitreous was significantly 
decreased in aphakic eyes compared with phakic ones.284 The loss of hyaluronic acid, a 
structural stabilizer of the vitreous, seems to predispose the vitreous to liquefaction and PVD. 
The exact clinical effect of this fact on the risk of RD is uncertain. 
 
3.5.2 Special characteristics  
The pseudophakic RD differs somewhat from a phakic one. Many retinal breaks are more 
anterior and smaller than in phakic RD and apparently created by zonular pull. In 15-20% no 
breaks are found even peroperatively.8;40;285-292 The visibility of peripheral retina is often more 
difficult because of semi-dilated pupil, rim of IOL and remnants of PCO even after LCT. 285;293 
Sometimes LCT must be done preoperatively to get better visualization or retinal periphery. 
 
3.5.3 Retinal detachment after LCT 
The most common potentially blinding complication of LCT is RD, which reportedly occurs in 
0.17% to 4.2% of treated eyes.12-15;36;139;140;142;143;145;147-150;153;249;252;271;294-302 The exact mechanism, 
which leads to RD is unclear, although several theories have been proposed.  
 
When LCT is done, a physiological barrier that persists after uncomplicated extracapsular 
cataract surgery is broken and the incidence of RD and CME increases.155;257;270 When 
examining the distribution of fluorescein in human eyes, it was found that the fluorescein 
diffused into the vitreous similarly after ICCE or capsulotomy, and significantly less in 
eyes with an intact posterior capsule.263 In another study, the in-the-bag fixated IOL best 
protected the barrier of the eye.270 Altered barrier effect may be related to the decreased 
hyaluronic acid content of the vitreous and thus to vitreous liquefaction. In experimental 
studies, loss of hyaluronic acid after capsulotomy occurs, leading first to vitreous 
degeneration and then via PVD to RD.281;284 It remains unclear whether Nd:YAG laser 
treatment is more likely to cause vitreous changes and retinal damage when used in an 
eye with pre-existing disturbance of the vitreous, for example in highly myopic eyes. 
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3.5.4 Treatment  
The treatment of pseudophakic RD differs somewhat from that of phakic eyes, mainly because 
of problems with visibility and characteristics of pseudophakic RD. There are several reports 
advocating the superiority of scleral buckling or vitrectomy as a primary procedure in 
pseudophakic RD, but this question remains controversial.303-308 To compare anatomic and 
functional results of these procedures, a randomized prospective study is recommended.  
 
3.5.5 Outcome  
The main factors related to the outcome of pseudophakic RD are the same as in phakic RD, 
i.e. preoperative BCVA and the duration of macular detachment.234;235 Lower anatomic 
success rates have been reported in eyes with anterior chamber IOLs.309-311 In other 
studies, however, it has been reported that the anatomic and visual results of reattachment 
surgery were much more influenced by characteristics of the detachment and by PVR than 
by techniques and complications of cataract surgery.285;286;312-314 With modern surgical 
techniques the anatomic success rate of pseudophakic RDs is reported to vary from 76% to 
99%.221;285-289;291;304-306;309-320 
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4 AIMS OF THE STUDY 
 
The purpose of this study was to better clarify the etiology, pathogenesis, characteristics and 
outcome of pseudophakic RD after Nd:YAG laser posterior capsulotomy. The main principle 
was to look for any differences between RDs that occur after cataract extraction in eyes with 
an intact posterior capsule as compared with those having undergone LCT (I). To identify 
clinically important features of RDs and to determine relative frequency of retinal holes or 
breaks, a retrospective study of the type and characteristics of RD after LCT was designed (I). 
 
A prospective follow-up study (II, III) was designed to find out whether there are significant 
numbers of asymptomatic retinal breaks in eyes scheduled for LCT, and if there will be some, 
at what stage they will develop. At the second stage of the study, it was important to find out 
whether fewer RDs took place in the subgroup, which had been closely followed and in which 
asymptomatic retinal breaks had been prophylactically photocoagulated. 
 
To compare the long-term outcome of pseudophakic RD in eyes with an intact posterior 
capsule and LCT, a cross-sectional analysis was done (IV). 
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5 PATIENTS AND METHODS 
 
5.1 PATIENTS 
Each study protocol was accepted by the Institutional Review Board of The Helsinki 
University Central Hospital, Department of Ophthalmology. All enrolled patients gave their 
written informed consent. 
 
5.1.1 Retrospective cohort study (I) 
The inclusion criteria into this retrospective cohort study were that an uncomplicated cataract 
extraction had been done to an eye that later developed a RD. From 1034 patients who had 
been operated on for primary rhegmatogenous RD in the Helsinki University Eye Hospital in 
years 1992-1996, 129 patients (eyes) fulfilled the inclusion criteria and were enrolled into the 
study. LCT had been performed on 61 of these eyes before RD (capsulotomy group), and in 68 
eyes the posterior capsule was intact (control group). 
 
5.1.2 Prospective studies (II, III) 
The inception cohort to the first stage of the prospective study (II) were 350 consecutive 
patients referred to a primary Nd:YAG LCT of a particular eye to Helsinki University Eye 
Hospital since October 1994.  
 
When determining the number of patients needed in the study, the null hypothesis was that 
no untreated retinal breaks are present in eyes referred for LCT and that no new breaks 
develop during this procedure. The alternative hypothesis was that the frequency of such 
retinal breaks would be at least 2%, based on the lowest frequency of retinal breaks in the 
general population. This was considered to be the minimum clinically significant frequency, 
given the 0.5% lower limit of the incidence of RD after LCT and presuming that not more than 
every fourth break might lead to RD in a capsulotomized eye. Setting alpha to 0.05 and beta to 
0.1, the minimum sample size required to discard the null hypothesis with 90% power was 
189 eyes. To allow for 10% loss to follow-up, the projected sample size was set at 210 eyes. A 
prospective follow-up of 5 years was planned. 
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The Stage I of the study was closed in February 1996. Inclusion criteria for this study were the 
patient’s written informed consent, a need for LCT, and visibility of the retinal circumference 
at least to the equator. 211 of 350 eligible patients (220 eyes) completed all three outpatient 
visits (inclusion rate, 60%). It was allowed that the patient could be enrolled later for LCT of 
his or her second eye. According to the Institutional Review Board, the patient was advised 
about the possibility of prophylactic treatment, and all patients in this study chose to have the 
asymptomatic retinal break treated. 
 
In Stage II (III), the 211 patients were invited to an outpatient visit. During the interim 52 of 
them had deceased, and 53 elected not to participate because of ill health, difficulties with 
traveling, or other social reasons. Thus 113 study eyes of 106 enrolled patients were re-
examined (inclusion ratio, 50%). In addition, patient charts of the primary inception cohort 
(350 eyes) were reviewed for retinal events.  
 
5.1.3 Cross-sectional study (III) 
The inclusion criteria in this retrospective, non-comparative, interventional series, were a 
pseudophakic RD after a strictly uncomplicated extracapsular cataract surgery and 
implantation of a posterior chamber IOL and a written informed consent. Those patients, who 
had had vitreous or posterior capsule complications during cataract surgery, were ineligible. 
138 of 1127 patients, who had been operated on for a primary rhegmatogenous RD in the 
Helsinki University Eye Hospital in 1990-1995 fulfilled the inclusion criteria and were invited 
to an outpatient visit. Of the 138 patients, 101 (73%) were enrolled. In addition to a 
retrospective chart review, clinical examination and a structured interview to determine 
patient satisfaction and quality of life were undertaken.  
 
5.2 METHODS 
5.2.1 Collection of retrospective data (I-IV) 
Most of the cataract extractions and Nd:YAG laser capsulotomies and all RD surgeries had 
been performed in the Helsinki University Eye Hospital. In this hospital, generally, cataract 
patients are operated on based on their residence, and only less than 5% of them are referred 
because more complicated surgery is anticipated. Half of the LCTs are done in this hospital, 
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and the other half are performed in private practices. If RD occurs, more than 90% of the 
catchment population will be operated on in this hospital. In the study population, all the RDs 
have been operated on at Helsinki University Eye Hospital by any of four vitreoretinal 
surgeons in charge. Missing clinical information was collected from other central, regional, 
and private hospitals where these patients had been treated and from private 
ophthalmologists responsible for the referral and follow-up.  
 
The age and gender of the patient, the axial length (AL), and the presence of other eye 
diseases, especially lattice degeneration, previous retinal breaks and RD were recorded. The 
type and course of cataract surgery, dates of LCT, cataract and RD surgeries, and the number 
and energy of laser applications were recorded. The characteristics of RD and the number, 
type and meridional location of retinal breaks were compiled from data registered in patient 
charts, the preoperative fundus drawings, and the findings made during detachment surgery. 
 
The type of retinal detachments was classified according to the scheme of Lincoff and Gieser 
321: type I included superior temporal or superior nasal detachments. For the purpose of this 
study, type II was divided into superior detachments that crossed the 12-o’clock meridian at 
least half an hour (type IIa) and into total detachments (type IIb).(Figure 5.) Type III included 
inferior detachments. Proliferative vitreoretinopathy (PVR) was graded according to the 
classification of the Retina Society.229 The type of retinal breaks was recorded as no visible 
break, a horseshoe tear, a round hole or group of adjacent holes related to one peripheral 
degenerative patch, or both types of breaks. 
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Figure 5. a-d The Modified Lincoff Scheme 
 
I. Superior temporal or nasal detachment
II a. Superior detachment crossing
the 12-o’clock meridian
II b. Total detachment
III Inferior detachment
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5.2.2 Clinical examination (II-IV) 
The best corrected visual acuity (BCVA) was determined using a test-type projector (Rodavist 
2, Rodenstock). The anterior segment was evaluated with a standard biomicroscope (Haag-
Streit, Köniz, Switzerland) and intraocular pressure was measured with a standard Goldmann 
applanation tonometer (Haag-Streit, Köniz, Switzerland). Pupils were dilated with 
tropicamide 0.5%, phenylnephrine hydrochloride 10%, and cyclopentolate hydrochloride 1% 
drops, instilled twice. 
 
The central fundus was examined with a +90 D convex lens (Volk Optical Inc., Mentor, Ohio, 
USA). The peripheral retina was evaluated using a binocular indirect ophthalmoscope, a +20D 
lens and scleral indentation, a Goldmann 3-mirror lens (Haag-Streit, Köniz, Switzerland) or a 
wide-field contact lens (QuadrAspheric, Volk Optical Inc., Mentor, Ohio, USA), whichever 
provided better visualization. Abnormal findings were recorded on a fundus chart.  
 
5.2.3 Nd:YAG laser posterior capsulotomy (II) 
The LCT was done by the surgeon in charge with a Q-switched Nd:YAG laser (Visulas YAG 
FL, Carl Zeiss). The type and shape of LCT was chosen according to the surgeon’s preference. 
The number of laser applications and their energies were recorded. Medication after 
capsulotomy was prescribed by the surgeon in charge on an individual basis. Generally before 
and after the LCT, a 1% apraclonidine drop was instilled to prevent IOP peaks. Fluorometolon 
eye drops were prescribed four times a day for one week. A photograph of the posterior 
capsule was taken (Zeiss 75 SL, Carl Zeiss) from which the largest diameter of the LCT was 
measured based on the magnification provided by the camera. 
 
5.2.4 Patient satisfaction and quality of life (IV) 
Patient satisfaction and quality of life were assessed by a structured interview that included 26 
questions (Figure 6.). These included two general questions, the first of which queried overall 
problems with vision and the second overall satisfaction with vision. In the third part, a set of 
6 questions originally designed for capturing symptoms potentially related to cataract 
(Cataract Symptom Score) 26;42;43;237 was asked in a way adapted to retinal symptoms. Patients 
who reported any of these symptoms were asked to which degree they bothered them. 
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Finally, the standard VF-14 test 42 was administered. The interviews were performed by the 
author, not by any of the vitreoretinal surgeons. 
 
Figure 6. Questionnaires used to evaluate functional vision 
 
 
 
 
 
OVERALL PROBLEMS WITH VISION 
 
1. Do you think you have difficulties with vision? 
1. None 
2. A little 
3. A moderate amount 
4. A great deal 
 
 
 
 
CATARACT SYMPTOM SCORE 
 
3. Are you bothered by double vision? 
Yes No 
If yes, how much it bothers? 
1. A little 
2. A moderate amount 
3. A great deal 
 
4. Are you bothered by glare? 
Yes No 
If yes, how much it bothers? 
1. A little 
2. A moderate amount 
3. A great deal 
 
5. Are you bothered by seeing halo or rings around light? 
Yes No 
If yes, how much it bothers? 
1.  A little 
2.  A moderate amount 
3.  A great deal 
 
 
 
OVERALL SATISFACTION WITH VISION 
 
2. How satisfied are you with your vision? 
1. Very unsatisfied 
2. Moderately unsatisfied 
3. Moderately satisfied 
4. Very satisfied 
 
 
 
 
 
6. Are you bothered by blurry vision? 
Yes No 
If yes, how much it bothers? 
1. A little 
2. A moderate amount 
3. A great deal 
 
7. Are you bothered by colors looking different than they used to in a 
way that is disturbing? 
Yes No 
If yes, how much it bothers? 
1. A little 
2. A moderate amount 
3. A great deal 
 
8. Are you bothered by distortion of pictures or straight lines? 
Yes No 
If yes, how much it bothers? 
1. A little 
2. A moderate amount 
3. A great deal 
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VF-14 
 
9. Do you have any difficulty, even with glasses, reading small 
print, such as labels on medicine bottles, a telephone book, food 
labels? 
Yes No Not applicable 
If yes, how much difficulty do you currently have?  
1. A little 
2. A moderate amount 
3. A great deal 
4. Are you unable to do the activity? 
 
10. Do you have any difficulty, even with glasses, reading a 
newspaper? 
Yes No Not applicable 
If yes, how much difficulty do you cu rrently have? 
1. A little 
2. A moderate amount 
3. A great deal 
4. Are you unable to do the activity? 
 
11. Do you have any difficulty, even with glasses, reading a 
large-print book or large-print newspaper or numbers on a 
telephone? 
Yes No Not applicable 
If yes, how much difficulty do you currently have?  
1. A little 
2. A moderate amount 
3. A great deal 
4. Are you unable to do the activity? 
 
12. Do you have any difficulty, even with glasses, recognizing 
people when they are close to you? 
Yes No Not applicable 
If yes, how much difficulty do you currently have? 
1. A little 
2. A moderate amount 
3. A great deal 
4. Are you unable to do the activity? 
 
13. Do you have any difficulty, even with glasses, seeing steps, 
stairs, or curbs? 
Yes No Not applicable 
If yes, how much difficulty do you currently ha ve? 
1. A little 
2. A moderate amount 
3. A great deal 
4. Are you unable to do the activity? 
 
14. Do you have any difficulty, even with glasses, reading traffic 
signs, street signs, or store signs? 
Yes No Not applicable 
If yes, how much difficulty do you currently have?  
1. A little 
2. A moderate amount 
3. A great deal 
4. Are you unable to do the activity? 
 
15. Do you have any difficulty, even with glasses, doing fine 
handwork like sewing, knitting, crocheting, carpentry? 
Yes No Not applicable 
If yes, how much difficulty do you curre ntly have? 
1. A little 
2. A moderate amount 
3. A great deal 
4. Are you unable to do the activity? 
 
16. Do you have any difficulty, even with glasses, writing checks 
or filling out forms? 
Yes No Not applicable 
If yes, how much difficulty do you currently have?  
1. A little 
2. A moderate amount 
3. A great deal 
4. Are you unable to do the activity? 
 
 
 
 
 
 
 
 
 
 
 
 
17. Do you have any difficulty, even with glasses, playing games 
such as bingo, dominos, card games, mahjong? 
Yes No Not applicable 
If yes, how much difficulty do you currently have? 
1. A little 
2. A moderate amount 
3. A great deal 
4. Are you unable to do the activity? 
 
 
18. Do you have any difficulty, even with glasses, taking part in 
sports like bowling, handball, tennis, golf? 
Yes No Not applicable 
If yes, how much difficulty do you curre ntly have? 
1. A little 
2. A moderate amount 
3. A great deal 
4. Are you unable to do the activity? 
 
19. Do you have any difficulty, even with glasses, cooking? 
Yes No Not applicable 
If yes, how much difficulty do you currently have?  
1. A little 
2. A moderate amount 
3. A great deal 
4. Are you unable to do the activity? 
 
20. Do you have any difficulty, even with glasses, watching 
television? 
Yes No Not applicable 
If yes, how much difficulty do you currently have?  
1. A little 
2. A moderate amount 
3. A great deal 
4. Are you unable to do the activity? 
 
21. Do you currently drive a car? 
Yes (go to 22) No (go to 24) 
 
22. How much difficulty do you have driving during the day 
because of your vision? Do you have: 
1. No difficulty 
2. A little difficulty 
3. A moderate amount of difficulty 
4. A great deal of difficulty? 
 
23. How much difficulty do you have driving at night because of 
your vision? Do you have: 
1. No difficulty 
2. A little difficulty 
3. A moderate amount of difficulty 
4. A great deal of difficulty? 
 
24. Have you ever driven a car? 
Yes (go to 25) No (stop) 
 
25. When did you stop driving? 
 Less than 6 months ago 
 6-12 months ago 
 More than 12 months ago 
 
26. Why did you stop driving? 
 Vision 
 Other illness 
 Other reason  
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5.2.5 Statistical analysis (I-IV) 
Statistical analyses were performed using the BMDP PC-90 Statistical Software package 
(BMDP Statistical Software, Cork, Ireland), the SPSS for Windows 9.0.1 (SPSS Inc., Chicago, 
Illinois, USA) and the STATA Statistics/Data Analysis Software Version 7.0 (Stata Co, Texas, 
USA). Descriptive statistics are given as a mean and standard deviation (SD) for normally 
distributed variables and as a median and range for other continuous variables. Confidence 
intervals (95%) were calculated for proportions. 
 
Fisher’s exact test and Pearson’s chi-square test with Yates’ continuity correction were used to 
compare proportions in 2x2 and larger unordered contingency tables, respectively.322 Singly 
ordered contingency tables were compared with the Kruskal-Wallis test. Means of continuous 
variables that did not follow normal distribution were compared with the nonparametric 
Mann-Whitney U-test.322 All tests were 2-tailed, and a P value less than 0.05 was considered 
significant. Multiple comparisons were adjusted for by the Bonferroni correction.322  
 
Calculation of the number of patients needed to discard the null hypothesis with 90% power 
(II) was done with StatMate (GraphPad Software, St. Diego, California). For calculating mean 
and median visual acuity (IV), the Snellen fractions were transformed to -logMAR (logarithm 
of the minimum angle of resolution) units. The results were transformed back to Snellen 
equivalents.  
 
Survival analysis (III, IV) was based on the Kaplan-Meier product-limit method.322;323 The time 
intervals from cataract surgery and LCT to RD were calculated and the cumulative 
proportions of patients with RD were compared between different groups using the log-rank 
test. Patients who died were censored from the analysis at the time of death and patients who 
did not develop RD were censored at the time of re-examination or chart review (III). 
 
Cox proportional hazards multiple regression322;323 was used to identify independent 
predictors of RD after LCT (III). Age at LCT and AL were analyzed as continuous variables. 
Alternatively, AL was arbitrarily dichotomized into two categories (≤25mm vs. >25mm). 
Categorical variables included gender, history of vitreous complication at the time of cataract 
surgery and enrollment status at Stage I of this study. Variables for which the Wald chi-square 
test gave a P value of <0.20 were considered for multivariate modeling, because of the small 
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number of events, so as not to discard potentially significant variables at an early stage. 
Moreover, only two variables at a time could legitimately be included in the multivariate 
model (III). 
 
Multiple logistic regression was used to model functional and patient-related visual outcomes 
(IV).322;323 Because logistic regression demands a two-category dependent variable, patient-
reported overall satisfaction with vision was dichotomized to satisfied and dissatisfied and 
overall problems with vision to those who had and did not have problems. The VF-14 score 
was also dichotomized so that scores below 90 were classified as low and scores of 90 or more 
as high scores. Likewise, the modified cataract symptom score was dichotomized to a low 
score (less than 3) and high score (3 or more). The cut points were chosen to correspond 
roughly with the median scores.  
 
The initial BCVA was modeled as a confounding variable, i.e. as a variable that theory dictates 
must always be included in the model. Each outcome variable was assessed as an 
independent variable in turn, i.e. statistical analysis was used to look for evidence of its 
association with the other variables: initial and final visual acuity, type of surgery, and 
number of RD procedures. As regards the independent variables analyzed, the type of RD 
surgery was dichotomized in two categories: scleral buckle only and vitrectomy with or 
without scleral buckle. Independent variables were allowed in the model if P <.10, and 
confounding variables were kept in the model irrespective of statistical significance. Different 
models were compared with the likelihood ratio test.  
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6 RESULTS AND DISCUSSION 
6.1 Characteristics of RD after LCT  
6.1.1 Time intervals between cataract extraction, LCT and RD (I, IV) 
In the retrospective study (I) and in the cross-sectional study (IV) the eyes with LCT were 
compared with those with an intact posterior capsule before RD. The median time interval 
from cataract extraction to RD was longer in the capsulotomy group (4.1 vs. 1.5 years, 3.2 vs. 
1.2 years, respectively, P<0.001, Mann-Whitney U-test,), as was to be expected because 
secondary cataract takes time to develop. The median time from LCT to RD was 2 years (range 
0.03-8.8). 28% of RDs occurred within 6 months after LCT (I).  
 
Frequently, most of the detachments occur within one year of LCT.271;285;293;294 The longer time 
in our study can be due to the fact that our patients had undergone a strictly uncomplicated 
cataract surgery. In many other studies the rate of vitreous complications varies or is not 
reported. 
6.1.2 Risk factors for RD 
At least one of the well-known risk factors for RD (lattice degeneration, high axial length, 
RD in the fellow eye) was present in 44% of pseudophakic eyes. No significant difference 
was detected between eyes with and without LCT (P = 0.86, Fisher’s exact test). More than 
one risk factor was present in 10% of the eyes (I). 
 
6.1.3 Type and extent of RD (I, IV) 
The type of RD as classified according to Lincoff types (P=0.17, Pearson’s chi-square test), by 
meridional locations (P=0.25, Mann-Whitney U-test), by the presence of macular detachment 
(P=0.47, Fisher’s exact test) and by proliferative vitreoretinopathy (PVR) (P=0.45, Pearson’s 
chi-square test) did not differ significantly between eyes with an intact posterior capsule and  
 
LCT. Of the RD 14-16% were total (P=0.16, Fisher’s exact test) and the macula was detached in 
64-65% of eyes (I, IV). 
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In previous studies, the types of post-capsulotomy RD have not differed notably from the 
present study.320 Such reports, however, which would have evaluated the type of RD in eyes 
with strictly uncomplicated cataract surgery, have not been published. 
 
6.1.4 Type, number and location of retinal breaks (I) 
The mean number of peripheral retinal breaks was higher in the capsulotomy group (1.7 vs. 
1.1, P=0.05, Mann-Whitney U test). The type and distribution of breaks also differed between 
the two study groups. The breaks were located especially in the upper quadrants in the 
capsulotomized eyes (82 of 103 vs. 48 of 77; P = 0.024, Fisher’s exact test with Bonferroni 
correction) and they tended to be more frequently atrophic holes than horseshoe breaks in 
these eyes (34 of 103 vs. 15 of 77; P = 0.062, Fisher’s exact test)(Figure 7.). 
 
 
Figure 7 A and B Number, type and distribution of retinal breaks in the capsulotomy and 
control group  
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This is the first report, in which the type and number of retinal breaks in eyes operated on for 
pseudophakic RD after strictly uncomplicated cataract extraction and LCT was analyzed, and 
so far the best controlled analysis of RD after LCT. The strict inclusion criteria were used to 
ensure that these two groups would not differ in other aspects than the status of the posterior 
capsule, which helps to spot differences. The difference in the number and the type of retinal 
breaks between the two groups could possibly be related to the increased risk of RD after LCT. 
Assuming this hypothesis is right, not only the horseshoe breaks, but also the atrophic holes 
could have a significant relation to RD, when alterations in vitreous structure happen after 
LCT.  
6.2 Retinal breaks associated with LCT  
6.2.1 Asymptomatic retinal breaks and RD before LCT (II) 
When examined before LCT, the retina could be visualized up to ora serrata in 177 of 235 
eyes (75%). An untreated, asymptomatic retinal break was noticed in 4 of the 235 enrolled 
eyes (1.7%, 95% CI 0-4)(Figure 8, white symbols). Furthermore, in 2 additional eyes (0.9%, 
95% CI 0-3) an undiagnosed RD (a chronic inferonasal RD without visible breaks and a 
total redetachment in a previously operated eye) was noticed. In 4 fellow eyes, an 
asymptomatic retinal break was detected. These breaks were not noticed by the private 
ophthalmologists who referred the patients to LCT. A previously treated break was detected 
in 2 study and 1 fellow eye.  
 
It is well known, that PCO often disturbs the retinal visibility. However, the visualization of 
peripheral retina was successful in the majority of eyes; the main problems were PCO and 
poorly dilated pupils.  
 
The incidence of asymptomatic retinal breaks in the general population is reported to be about 
6%.8 The observed frequency of asymptomatic retinal breaks in this study was smaller but 
corresponds with the 0.5-2.0% frequency of RD after LCT. If we take into account all breaks, 
previously treated and asymptomatic ones now detected, the frequency was roughly the 
same. The proportion of breaks, which finally will lead to RD is not well established. No 
prospective study of the progression of a symptomatic retinal break in pseudophakic and 
Results and Discussion 
 
46 
capsulotomized eyes have been published.199 However, we can conclude that a significant 
proportion of eyes scheduled for LCT have an asymptomatic retinal break. 
When there are recognized risk factors, which predispose the eye to premature PVD and to 
subsequent RD, such as high myopia, history of RD in the fellow eye and vitreous loss during 
cataract surgery, most ophthalmologists would consider it reasonable to treat such breaks 
prophylactically before LCT. 
 
6.2.2 Retinal breaks after LCT (II) 
The median single and total energy used in LCT were 2.3 mJ and 51 mJ, respectively, which 
were moderate as compared with the literature (range of means of total energy, 13-118 mJ). 
The amount of energy (single or total) have not been shown to correlate the risk of 
RD.16;17;147;252;266;295;300;324-326 The median largest diameter of the capsulotomy was 3.4 mm 
(range, 2.0 to 4.6 mm).  
 
When examined a median of 60 minutes after LCT, no new breaks, retinal hemorrhages or 
other adverse effects from the LCT were noted. The ora serrata was visualized in 160 of 223 
eyes (72%). In addition to remnants of PCO, poorly dilating pupils, also some corneal edema 
and dry epithelium were noticed to deteriorate the visibility. 
 
One month after LCT a new break was found and photocoagulated in 1 of 220 (0.4%, 95% CI 0-
3) eyes: an asymptomatic superotemporal horseshoe tear bordering a previously seen lattice 
degeneration adjacent to a previously treated break (Figure 8, black symbol). The axial length 
of this eye was 24.8 mm. No new RDs were detected, nor was vitreous prolapse through the 
LCT found in any eye. The ora serrata could be visualized in 196 of 220 eyes (89%).  
 
In some eyes, previously uncertain findings in the very anterior retina could be visualized 
better after LCT. Some of the findings were confirmed as retinal breaks, but others as harmless 
atrophic degenerations. It is possible that the horseshoe break detected one month after LCT 
may have existed even before LCT, even though the lattice degeneration and the previously 
treated break nearby were detected before LCT. 
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Figure 8. Type and location of asymptomatic, previously untreated retinal breaks in eyes 
scheduled for LCT 
 
 
6.2.3 Later retinal breaks (III) 
Later, 113 eyes of 106 patients were re-examined after a median follow-up time of 4.9 years. 
The ora serrata was visible in 76 of 113 eyes (67%). The reasons to poor visibility were again 
poorly dilating pupil (20% of eyes), corneal opacities, remnants of secondary cataract, poor co-
operation and vitreous opacities in the minority of cases. In one patient with floaters in the 
study eye, an operculated superotemporal break associated with retinal pigmentation was 
found and sealed with argon laser photocoagulation. No new asymptomatic breaks were 
noticed, and the retina was attached in all eyes.  
 
At Stage II, 3 of 5 study eyes with a treated break and 2 of the 4 fellow eyes with an untreated 
break, (none of which had had LCT), were re-examined. No new breaks nor subretinal fluid 
around the previously detected breaks were detected. 
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6.2.4 Prospective study of RD after LCT (III) 
 
In the prospective study (III), 8 of 350 eyes developed a RD within the five-year follow-up. 
Two of these RDs occurred in previously examined eyes that had asymptomatic retinal breaks 
photocoagulated, and six in eyes with unknown retinal status at the time of LCT. In four eyes 
a new horseshoe tear was found. In one eye a typical macular hole was detected, and in three 
other eyes no peripheral retinal breaks were found even peroperatively (Figure 9.). 
 
In 7 patients, at least one of the risk factors for RD was present (III). By Cox regression 
analysis, the axial length showed statistically significant association with RD after LCT, 
whether modeled as a continuous variable (HR 1.51 for each mm increase, P=0.0002) or 
categorized by using 25 mm as a cutoff (HR 11.1 P=0.0016). RD was also associated with male 
gender (HR 3.61), younger age at LCT (HR 1.45 for each 10-year decrease in age), and non-
enrollment to Stage I of this study (HR 4.95). However, with bivariate Cox regression models 
vitreous complications at cataract surgery showed to be a statistically significant predictor of 
RD (HR 11.9, P=0.036), as did the enrollment status.  
 
Figure 9. Type and location of retinal breaks in eyes with retinal detachment after LCT 
 
This kind of prospective study in eyes undergoing LCT has not been previously reported. In 
the group of prophylactically treated eyes, the incidence of RD was lower than among other 
eyes. This study was not randomized nor controlled. However, fellow eyes of enrolled 
patients had RD equally often as non-participating eyes. No RD developed in non-
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capsulotomized fellow eyes. It is suggestive of potential benefit as regards non-horseshoe, 
non-PVD-related breaks developing. A larger study of patients randomized to undergo 
thorough fundus examination or no such examination, is needed to confirm these results. It 
seems probable that also other risk factors than LCT such as high axial length have an effect 
on the RD after LCT. Therefore it seems reasonable to advice patients with high risk eyes to 
attend ophthalmologic controls to detect existing retinal degenerations in advance and 
especially contact their ophthalmologist if they have any visual symptoms. The randomized 
study also might be focused on patients at high risk of RD. 
 
6.3 Long-term outcome of pseudophakic retinal detachment after LCT  
6.3.1 Anatomic outcome (IV) 
In the cross-sectional study after RD surgery, the retina was reattached in 75 eyes with a single 
procedure (74%, 95% CI 65-82). In 98 eyes (97%, 95 CI 92-99) two procedures were needed to 
reattach the retina. In all 101 eyes (95 CI 96-100) retina was attached with 3 to 5 procedures.  
 
The presence of LCT was not statistically significantly associated with primary redetachment 
(20% vs. 31%, P=0.25, Fisher’s exact test). During a median follow-up of 4.3 years, a later 
detachment had occurred in 8 eyes (8%, 95% CI 3-15), and at the re-examination, one 
asymptomatic redetachment was diagnosed. Thus the retina remained attached long-term in 
92% of pseudophakic eyes (95 CI 84-96), which corresponds to the reported rate of success in 
literature.8 The presence of LCT was not associated with later redetachment (9% vs. 9 %, P = 
1.0, Fisher’s exact test). The number of eyes in which retinal breaks were not found even 
peroperatively (22%), was comparable to other studies, especially as regards pseudophakic 
eyes.8;40 
 
It is good to know, that the presence of LCT does not compromise later RD surgery. Moreover, 
if the opacified posterior capsule is opened, improvement in visibility of peripheral retina can 
be expected, thus making the closure of retinal breaks easier. 
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6.3.2 Objective visual outcome (IV) 
In eyes with pseudophakic RD the median BCVA in Snellen symbols was 0.08 before RD 
surgery and 0.4 at re-examination, a median of 4.9 years after last vitreoretinal surgery. There 
was no statistically significant difference in BCVA between eyes with an intact posterior 
capsule or LCT. The BCVA at re-examination was 0.5 or better in Snellen symbols in 39% of all 
eyes. The median BCVA in the fellow eyes was 0.7 in both groups. 
 
The median diameter of the Goldmann visual field of the operated eye was 100° horizontally 
and 90° vertically for eyes with and without LCT. This is somewhat less than the normal range 
in the same age group of healthy eyes327 due to indentation of scleral buckle, scars of 
cryocoagulation and the IOL. No statistically significant difference between the two groups 
was observed. 
 
The final BCVA depends mainly on the presence and duration of macular detachment.8 It has 
been reported, that if RD is repaired within one week of the macular detachment, the visual 
results in long-term may be as good as if it is operated within 24 hours, as an emergency.8 
 
6.3.3 Patient-rated functional outcome (IV) 
The functional outcome of RD surgery in the cross-section study was good and no statistically 
significant differences existed between patients with and without LCT in any of the 
questionnaires.  
 
The median VF 14-score was 87.5 for both groups (the more points, the less difficulties in 
performing the activities, score 0-100, P = 0.81, Mann-Whitney U-test). The median modified 
cataract symptom score was 3.0 for both groups (the less points, the less symptoms, score 0-18, 
P = 0.76, Mann-Whitney U-test). Of 100 patients who answered the questionnaire, 80 (80%) 
were satisfied or very satisfied with their binocular vision (P = 0.40, Pearson’s chi-square test), 
and 62 (62%) reported no or just a little trouble with binocular vision (P = 0.64, Pearson’s chi-
square test).  
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By a multiple logistic regression analysis the final best corrected visual acuity (BCVA) was 
independently associated with initial BCVA (modeled as a confounding factor), type of RD 
surgery and number of procedures. Poor initial BCVA, vitrectomy with or without scleral 
buckling and more than one procedure predicted poor final visual acuity. The final BCVA was 
also statistically significantly associated with overall satisfaction and problems of vision.  
 
It is known from previous reports, that a poorer initial VA predicts a poor final BCVA.8 As 
mentioned, the final BCVA depends largely on the status of the macula, which corresponds to 
preoperative BCVA. The association between final BCVA and vitrectomy is explained by the 
common practice using primarily scleral buckling, and reverting to vitrectomy only in more 
complicated eyes and as a secondary procedure. Vitrectomy is an efficient and safe procedure 
and does not compromise VA by itself. Several reports have been published of using 
vitrectomy as the primary procedure in pseudophakic RD repair with good results, but in 
most countries like Finland, scleral buckling remains the predominating procedure. In the 
present series, 70% of eyes were operated on with a scleral buckle, and 29% required vitreous 
surgery with or without scleral buckling. The presence of LCT was not associated with the 
type of surgery required (P = 0.26, Pearson’s chi-square test). 
 
Previously questionnaires have been widely used to asses cataract surgery, and gradually 
some results regarding other eye diseases have been published.51-53;238;240-242;328-330 From the 
viewpoint of the patient, it is easier to compare the pre- and postoperative vision after cataract 
surgery, because cataract takes time to develop. Because RD must be operated very soon, 
within days, the situations are changing more quickly. This may explain lack of this kind of 
studies in the acute phase. On the other hand, they are probably valid in reflecting later visual 
performance. Compared to the previous analyses of functional outcome of vitreoretinal 
procedures, the level of VF-14 and other scores were very similar.53;240-242;331  
 
It is known that the visual acuity gradually improves after RD surgery, and small changes 
may happen during the first postoperative year.8 The risk for redetachment is also at its 
greatest during the first postoperative year. Thus when estimating the final results of RD 
surgery, it should not be done too soon after the surgery. 
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When estimating how much the visual problems influence the every-day life of the patient, it 
must be remembered that the bilateral visual acuity and the extent of visual fields are of 
particular importance. In this analysis, the median BCVA of the fellow eyes was 0.7 in Snellen 
fractions, which may have a beneficial influence on the results of the questionnaires. Also the 
status of the dominant eye is important. In our study, the dominance of either eye was not 
recorded. 
 
The functional way of measuring the outcome of the surgery is coming more and more 
important. VF-14 is a widely used questionnaire originally planned for cataract surgery. 
However, using just one questionnaire for young and old people, for different eye diseases 
and surgeries and for patients in different countries and with lifestyles of their own, has also 
limitations. The ideal way to measure the functional vision could be one basic questionnaire 
with additional questions or modules aimed at specific targets such as vitreoretinal diseases. 
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7 SUMMARY AND CONCLUSIONS 
 
Retinal detachment is the most common potentially blinding complication after cataract 
surgery. When Nd:YAG laser posterior capsulotomy (LCT) is performed to open an opacified, 
but previously intact posterior capsule, the risk of RD is thought to increase four times.10-12 
Because cataract surgery is the most frequent surgical procedure in the world, and visually 
significant posterior capsule opacification develops nowadays in 20-25% of pseudophakic 
eyes, the risk of RD is notable. 
 
Although unknown, the exact pathogenetic mechanisms of RD after LCT are supposed to 
relate to secondary vitreous changes. This clinically orientated study was designed to find out 
more of the properties of RD after LCT. To exclude bias from vitreous complications, one of 
the main principles throughout the study was to not enroll eyes with a posterior capsule 
rupture to retrospective analysis and to use prospective approach when possible. 
 
In the first part of the study it was noticed that the number and distribution of retinal breaks 
were different between eyes with and without LCT. The LCT group had significantly more 
retinal breaks, particularly more atrophic holes located in the superior quadrants. Otherwise 
the characteristics of RD were equal in both groups. Data on the presence of asymptomatic 
retinal breaks before LCT and their possible progression to RD afterward could not be 
achieved from this retrospective chart analysis, but the results were used to design the second 
part of the study.  
 
At Stage I of the second, prospective study 235 eyes were examined before and after LCT, and 
an asymptomatic, untreated retinal break was found in 1.7% of eyes. A previously treated 
break was detected in 2 eyes. Furthermore, one month after LCT, a new asymptomatic break 
in one eye was noticed. All patients with an untreated retinal break in the eye scheduled for 
LCT chose to have prophylactic photocoagulation.  
 
At Stage II of the prospective study, the overall cumulative proportion of patients with RD at 5 
years was significantly less among the enrolled eyes as compared with eyes, which were not 
prospectively followed and prophylactically treated, in spite of relatively small amount of 
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patients (proportion of RD 1.2% vs. 5.8%, respectively, Kaplan-Meier). In these eyes, known 
risk factors such as high axial length seemed decisive as regards the development of RD. I am 
unaware of other prospective studies of retinal breaks and detachment after LCT.  
 
In the third part of the study the final anatomic, visual and functional outcome of 
pseudophakic RD was equal in eyes with and without LCT. The retina had remained attached 
in 91% of eyes, and BCVA better than 0.5 in Snellen symbols was acquired in 39% of eyes. 
These anatomical and visual results are comparable to other reports of the outcome of 
pseudophakic RD.  
 
Only preliminary studies about the patient-related functional results of vitreoretinal surgery 
have been published and in them patients with RD (phakic, aphakic or pseudophakic) have 
been but a small subgroup. If RD occurs, the anatomic and functional results seem to be equal 
in eyes with and without a LCT. When performing vitreoretinal surgery because of RD, the 
LCT is even advantageous in improving the visibility of peripheral retina.  
 
In conclusion, this series of studies showed that in eyes scheduled for LCT, risk factors, such 
high axial length, have to be taken into account. It may be important to examine the peripheral 
retina carefully perioperatively and to continue follow-up after LCT. A prospective study of a 
much larger population of patients would be required to document statistically a benefit from 
treatment of the break and to quantitate the probable risk of RD from leaving it untreated. 
Until that time, if asymptomatic retinal breaks are found, prophylactic photocoagulation is 
worth considering because of the known and potentially additive risk of LCT on RD.  
 
To minimize the time from symptoms to diagnosis and treatment of RD, it is important to 
inform the LCT patient of such symptoms, and advice a prompt ophthalmological 
examination. On the other hand, in spite of increased risk of RD, there is no reason to defer 
LCT, when it is otherwise indicated and appropriately done. In eyes with several, often 
additive risk factors, the cautious ophthalmologist will have a higher threshold in performing 
LCT, and he or she will pay close attention to preoperative assessment and follow-up. To 
prevent this type of RD from developing in the future, it is also important to further identify 
and minimize any controllable factors contributing to opacification of the posterior capsule. 
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